Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
G Villacampa, N M Tung, S Pernas, et al.
ESMO Open
|
October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]
E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival
Y Wang, D Drubay, S F Jonas, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
G Villacampa, N M Tung, S Pernas, et al.
ESMO Open
|
October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]
E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival
Y Wang, D Drubay, S F Jonas, et al.
Page
of 5